Literature DB >> 15937518

Characterisation of cell-penetrating peptide-mediated peptide delivery.

Simon W Jones1, Richard Christison, Ken Bundell, Catherine J Voyce, Sarah M V Brockbank, Peter Newham, Mark A Lindsay.   

Abstract

Cell-penetrating peptides such as antennapedia, TAT, transportan and polyarginine have been extensively employed for in vitro and in vivo delivery of biologically active peptides. However, little is known of the relative efficacy, toxicity and uptake mechanism of individual protein transduction domain-peptide conjugates, factors that will be critical in determining the most effective sequence. In the present study, we show by FACS analysis that unconjugated antennapedia, TAT, transportan and polyarginine demonstrate similar kinetic uptake profiles, being maximal at 1-3 h and independent of cell type (HeLa, A549 and CHO cell lines). A comparison of the magnitude of uptake of cell-penetrating peptide conjugates demonstrated that polyarginine=transportan>antennapedia>TAT. However, examination of cellular toxicity showed that antennapedia<TAT<transportan< intersectionpolyarginine, with antennapedia-peptide conjugates having no significant toxicity even at 100 microM. Confocal studies of the mechanism of antennapedia- and TAT-peptide uptake showed that the time course of uptake and their cellular distribution did not correlate with transferrin, a marker of clathrin-mediated endocytosis. In contrast, the peptides co-localised with a marker of lipid rafts domains, cholera toxin, which was attenuated following the disruption of these domains using methyl-beta-cyclodextrin. Overall, comparison of the uptake and toxicity suggests that antennapedia provides the optimal cell-penetrating peptide for peptide delivery in vitro and that both antennapedia- and TAT-mediated peptide delivery occurs predominantly via lipid raft-dependent but clathrin-independent endocytosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15937518      PMCID: PMC1576229          DOI: 10.1038/sj.bjp.0706279

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  49 in total

Review 1.  Cell-penetrating peptides.

Authors:  M Lindgren; M Hällbrink; A Prochiantz; U Langel
Journal:  Trends Pharmacol Sci       Date:  2000-03       Impact factor: 14.819

Review 2.  Protein transduction technology.

Authors:  Jehangir S Wadia; Steven F Dowdy
Journal:  Curr Opin Biotechnol       Date:  2002-02       Impact factor: 9.740

3.  Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions.

Authors:  Michelle Aarts; Yitao Liu; Lidong Liu; Shintaro Besshoh; Mark Arundine; James W Gurd; Yu-Tian Wang; Michael W Salter; Michael Tymianski
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

4.  Inhibition of neuronal apoptosis in vitro and in vivo using TAT-mediated protein transduction.

Authors:  Gunnar P H Dietz; Ertugrul Kilic; Mathias Bähr
Journal:  Mol Cell Neurosci       Date:  2002-09       Impact factor: 4.314

Review 5.  Peptide-mediated cell delivery: application in protein target validation.

Authors:  Mark A Lindsay
Journal:  Curr Opin Pharmacol       Date:  2002-10       Impact factor: 5.547

6.  Intravenous TAT-Bcl-Xl is protective after middle cerebral artery occlusion in mice.

Authors:  Ertugrul Kilic; Gunnar P H Dietz; Dirk M Hermann; Mathias Bähr
Journal:  Ann Neurol       Date:  2002-11       Impact factor: 10.422

7.  Possible existence of common internalization mechanisms among arginine-rich peptides.

Authors:  Tomoki Suzuki; Shiroh Futaki; Miki Niwa; Seigo Tanaka; Kunihiro Ueda; Yukio Sugiura
Journal:  J Biol Chem       Date:  2001-11-15       Impact factor: 5.157

8.  Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat.

Authors:  Michelle Silhol; Mudit Tyagi; Mauro Giacca; Bernard Lebleu; Eric Vivès
Journal:  Eur J Biochem       Date:  2002-01

9.  Trojan p16 peptide suppresses pancreatic cancer growth and prolongs survival in mice.

Authors:  Ryo Hosotani; Yoshiharu Miyamoto; Koji Fujimoto; Ryuichiro Doi; Akira Otaka; Nobutaka Fujii; Masayuki Imamura
Journal:  Clin Cancer Res       Date:  2002-04       Impact factor: 12.531

10.  In Vivo Delivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects against Ischemic Brain Injury and Neuronal Apoptosis.

Authors:  Guodong Cao; Wei Pei; Hailiang Ge; Qinhua Liang; Yumin Luo; Frank R Sharp; Aigang Lu; Ruiqiong Ran; Steven H Graham; Jun Chen
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

View more
  88 in total

1.  Analysis of protein kinase A activity in insulin-secreting cells using a cell-penetrating protein substrate and capillary electrophoresis.

Authors:  Femina Rauf; Yiding Huang; Thusitha P Muhandiramlage; Craig A Aspinwall
Journal:  Anal Bioanal Chem       Date:  2010-05-12       Impact factor: 4.142

2.  Use of a penetratin-linked peptide in Dictyostelium.

Authors:  W Jonathan Ryves; Adrian J Harwood
Journal:  Mol Biotechnol       Date:  2006-06       Impact factor: 2.695

Review 3.  The taming of the cell penetrating domain of the HIV Tat: myths and realities.

Authors:  Ashok Chauhan; Akshay Tikoo; Arvinder K Kapur; Mahavir Singh
Journal:  J Control Release       Date:  2006-11-17       Impact factor: 9.776

4.  Efficient Intracellular Delivery of a Pro-Apoptotic Peptide With A pH-Responsive Carrier.

Authors:  Brian Albarran; Allan S Hoffman; Patrick S Stayton
Journal:  React Funct Polym       Date:  2011-03-01       Impact factor: 3.975

Review 5.  The design of guanidinium-rich transporters and their internalization mechanisms.

Authors:  Paul A Wender; Wesley C Galliher; Elena A Goun; Lisa R Jones; Thomas H Pillow
Journal:  Adv Drug Deliv Rev       Date:  2007-11-09       Impact factor: 15.470

6.  Cell-permeable beta-peptide inhibitors of p53/hDM2 complexation.

Authors:  Elizabeth A Harker; Alanna Schepartz
Journal:  Chembiochem       Date:  2009-04-17       Impact factor: 3.164

Review 7.  Efficient siRNA delivery with non-viral polymeric vehicles.

Authors:  Won Jong Kim; Sung Wan Kim
Journal:  Pharm Res       Date:  2008-11-18       Impact factor: 4.200

Review 8.  Cell penetrating peptide inhibitors of nuclear factor-kappa B.

Authors:  J S Orange; M J May
Journal:  Cell Mol Life Sci       Date:  2008-11       Impact factor: 9.261

9.  Caveolin-1 regulates human immunodeficiency virus-1 Tat-induced alterations of tight junction protein expression via modulation of the Ras signaling.

Authors:  Yu Zhong; Eric J Smart; Babette Weksler; Pierre-Olivier Couraud; Bernhard Hennig; Michal Toborek
Journal:  J Neurosci       Date:  2008-07-30       Impact factor: 6.167

10.  Protein delivery using Cys2-His2 zinc-finger domains.

Authors:  Thomas Gaj; Jia Liu; Kimberly E Anderson; Shannon J Sirk; Carlos F Barbas
Journal:  ACS Chem Biol       Date:  2014-06-19       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.